UK markets close in 7 hours 39 minutes

AbbVie Inc. (0QCV.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
89.63+9.15 (+11.37%)
As of 11:39AM GMT. Market open.
Sign in to post a message.
  • S
    SushaG
    Accumulate, hold, repeat.

    Great company, great dividend, long term winner.
  • T
    Terry
    With market for H deteriorating rapidly comvined with the epic failures of their drug pipeline and acquisitions....it's not going to take much ..... 83 billion in debt....holders should be sweating profusely...
  • m
    michael k
    FDA Approves First Interchangeable Humira Biosimilar -- Market Talk
    12:23 pm ET October 18, 2021 (Dow Jones) Print
    1223 ET - The FDA gives the green light to Boehringer Ingelheim's Cyltezo as the first interchangeable biosimilar to AbbVie's blockbuster Humira, the world's biggest-selling drug, which is used to treat diseases from rheumatoid arthritis to gut disorders. The FDA originally approved Cyltezo in 2017 for multiple chronic inflammatory diseases, and the new designation makes it interchangeable across the indications, meaning it can be substituted without the prescriber having to change the prescription. AbbVie has successfully used patent litigation to fend off the entry of Humira biosimilars. Boehringer Ingelheim struck a deal with AbbVie in 2019 that let the German company launch its Humira rival in July 2023
  • X
    Xid
    Successful people don't become that way overnight. What most people see at a glance wealth, a great career, purpose is the result of hard work and hustle over time. I pray that anyone reads this will be successful in life
  • m
    michael k
    AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Active Psoriatic Arthritis in the European Union (EU)
    Fri, October 15, 2021, 7:35 AM
  • S
    SamIAm
    ISRG reports ah with ABT in the morning. Maybe we'll get a jolt. My biotechs have been underperforming terribly lately.
  • X
    XFrank
    way oversold, forward PE 7.82: strong buy
  • M
    Matt Schreyer
    Ex divi digested. Yummy 😋
  • L
    Liam
    look at some of these trades on Nasdaq after hours

    After Hours Time (ET) After Hours Price After Hours Share Volume
    16:06:16 $108.46 1
    16:06:11 $108.52 3
    16:05:34 $108.57 9,791
    16:04:58 $108.51 2
    16:04:57 $108.51 25
    16:04:52 $108.435 1
    16:04:52 $108.52 1
    16:04:32 $108.57 9,350
    16:03:49 $108.48 5
    16:03:21 $108.43 1
    16:03:19 $108.5 25
    16:02:35 $108.52 100
    16:02:27 $108.52 10
    16:02:27 $108.57 306
    16:02:27 $108.57 942
    16:02:27 $108.57 162
    16:02:26 $108.57 20,728
    16:02:26 $108.57 4,487
    16:02:26 $108.57 1,580
    16:02:26 $108.57 2,187
  • R
    Rob
    STRONG BUY HERE AT THESE LEVELS , collect you’re dividends
  • S
    Stockguru
    Being manipulated once again!
  • m
    michael k
    Health Canada Approves the Use of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Moderate to Severe Atopic Dermatitis
    Thu, October 7, 2021, 12:22 PM
  • M
    MD
    abbv is down cause of EX DIV
  • m
    michael k
    FDA Approves QULIPTA™ (atogepant), the First and Only Oral CGRP Receptor Antagonist Specifically Developed for the Preventive Treatment of Migraine
    Tue, September 28, 2021, 6:42 PM
  • J
    JimCramer
    Of course, I'm going to continue buying while the price is down.
    Warren Buffet always says when others are greedy be fearful and when others are fearful be greedy!!!
    Well on Warren Buffet's advice I did my research and I will be very GREEDY and buy as much ABBV as I can afford!
  • J
    Jenny
    Guys
    you do know that this is all smoke and mirrors from shorts trying to buy in cheaper
  • J
    JimCramer
    watch ABBV be over 116.00 next week
    Keep pushing your short b.s and watch what happens
  • k
    kenneth
    Do you have money in the money market? Put it here, collect about five times as much and ignore the fluctuations
  • A
    Anonymous
    ABBV is one of the oversold pharma stocks. Buy.
  • S
    SamIAm
    We are past the ex-divy dip I think.